Tuesday, December 19, 2017

FDA takes more aggressive stance toward homeopathic drugs

The Food and Drug Administration on Monday proposed a tougher enforcement policy toward homeopathic drugs, saying it would target products posing the greatest safety risks, including those containing potentially harmful ingredients or being marketed for cancer, heart disease and opioid and alcohol addictions.

No comments:

Post a Comment